A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors

I Braenne, C Willenborg, V Tragante, T Kessler, LY Zeng, B Reiz, M Kleinecke, S von Ameln, CJ Willer, M Laakso, PS Wild, T Zeller, L Wallentin, PW Franks, V Salomaa, Abbas Dehghan, T Meitinger, NJ Samani, FW Asselbergs, J ErdmannH Schunkert

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)
Original languageUndefined/Unknown
Article number10252
JournalScientific Reports
Publication statusPublished - 2017

Cite this